These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2885938)

  • 1. Correlations between embryotoxic and genotoxic effects of phenytoin in mice.
    Barcellona PS; Barale R; Campana A; Zucconi D; Rossi V; Caranti S
    Teratog Carcinog Mutagen; 1987; 7(2):159-68. PubMed ID: 2885938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
    Fort DJ; Bantle JA
    Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
    Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phenytoin bioactivation and teratogenicity by dietary n-3 fatty acids in mice.
    Kubow S
    Lipids; 1992 Sep; 27(9):721-8. PubMed ID: 1487972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in phenytoin biotransformation and susceptibility to congenital malformations: a review.
    Van Dyke DC; Berg MJ; Olson CH
    DICP; 1991 Sep; 25(9):987-92. PubMed ID: 1683079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
    Martz F; Failinger C; Blake DA
    J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryotoxicity of phenytoin in adrenalectomized CD-1 mice.
    Hansen DK; Branham WS; Sheehan DM; Holson RR
    Proc Soc Exp Biol Med; 1992 Apr; 199(4):501-8. PubMed ID: 1549630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochrome P450-mediated metabolism and identification of novel thiol-conjugated metabolites in mice with phenytoin-induced liver injury.
    Sasaki E; Iwamura A; Tsuneyama K; Fukami T; Nakajima M; Kume T; Yokoi T
    Toxicol Lett; 2015 Jan; 232(1):79-88. PubMed ID: 25455449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxicology of chemical interactions during pregnancy in the mouse: caffeine and phenytoin.
    Skalko RG; Poche PD; Kwasigroch TE
    Toxicology; 1984 Feb; 30(1):7-16. PubMed ID: 6701907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
    Yu WK; Wells PG
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin: an evaluation of several potential teratogenic mechanisms.
    DeVore GR; Woodbury DM
    Epilepsia; 1977 Sep; 18(3):387-96. PubMed ID: 891492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
    Kim PM; Winn LM; Parman T; Wells PG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of paracetamol by highly purified forms of cytochrome P-450.
    Steele CM; Masson HA; Battershill JM; Gibson GG; Ioannides C
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):109-19. PubMed ID: 6867468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzo(a)pyrene metabolism by purified forms of rabbit liver microsomal cytochrome P-450, cytochrome b5 and epoxide hydrase in reconstituted phospholipid vesicles.
    Brunström A; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 1980 Jul; 95(1):431-9. PubMed ID: 7417266
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of route of administration on phenytoin teratogenicity in A/J mice.
    Hansen DK; Billings RE
    J Craniofac Genet Dev Biol; 1986; 6(2):131-8. PubMed ID: 3722339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on phenytoin-induced embryopathy in mice.
    Wells PG; Vo HP
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):398-405. PubMed ID: 2609339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains.
    Sezzano P; Raimondi A; Arboix M; Pantarotto C
    Mutat Res; 1982 Mar; 103(3-6):219-28. PubMed ID: 7045642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphenylhydantoin is not genotoxic in a battery of short-term cytogenetic assays.
    Kindig D; Garriott ML; Parton JW; Brunny JD; Beyers JE
    Teratog Carcinog Mutagen; 1992; 12(1):43-50. PubMed ID: 1354899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interaction between phenytoin and allopurinol.
    Ogiso T; Ito Y; Iwaki M; Tsunekawa K
    J Pharmacobiodyn; 1990 Jan; 13(1):36-43. PubMed ID: 2341968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.